menu search

TBRIF / Therma Bright plots a course to build on 2022 product development in end-of-year shareholder letter

Therma Bright plots a course to build on 2022 product development in end-of-year shareholder letter
Therma Bright Inc (TSX-V:THRM, OTC:TBRIF), the developer of the smart-enabled AcuVid COVID-19 rapid antigen saliva test, has released an end-of-year shareholder update with comments from CEO Rob Fia.  "2022 was a busy year for Therma Bright with many accomplishments and new endeavors,” Fia said in the update. Read More
Posted: Dec 21 2022, 09:26
Author Name: Proactive Investors
Views: 110711

TBRIF News  

Therma Bright appoints Eric Myung as new CEO

By Proactive Investors
October 2, 2023

Therma Bright appoints Eric Myung as new CEO

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) told investors that Eric Myung has assumed the role of the company's new chief financial officer (CFO) with more_horizontal

Therma Bright says permanent insurance codes for Venowave expected over coming weeks

By Proactive Investors
August 4, 2023

Therma Bright says permanent insurance codes for Venowave expected over coming weeks

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said that in the coming weeks, it expects a final decision on permanent codes from the Centers for Medicare more_horizontal

Therma Bright in talks with US Health and Human Services over permanent medical device codes

By Proactive Investors
June 30, 2023

Therma Bright in talks with US Health and Human Services over permanent medical device codes

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has been engaged in discussions with the US Department of Health and Human Services (DHHS) over the more_horizontal

Therma Bright seeking commercialization opportunities for its AI-driven Digital Cough Technology

By Proactive Investors
June 22, 2023

Therma Bright seeking commercialization opportunities for its AI-driven Digital Cough Technology

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF). announced that it has begun investigating opportunities to commercialize and monetize its artificial intel more_horizontal

Therma Bright hails successful Good Laboratory Practice study for breakthrough PREVA mechanical thrombectomy device

By Proactive Investors
June 8, 2023

Therma Bright hails successful Good Laboratory Practice study for breakthrough PREVA mechanical thrombectomy device

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) along with its partner Inretio Inc has highlighted the successful completion of a Good Laboratory Practice more_horizontal

Therma Bright expands Venowave's US distribution to boost sales using Medicaid and Medicare reimbursement codes

By Proactive Investors
May 25, 2023

Therma Bright expands Venowave's US distribution to boost sales using Medicaid and Medicare reimbursement codes

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it is working with its US distributor network on expanding sales of Venowave under the nine t more_horizontal

Therma Bright kicks off data collection with AI App at tuberculosis clinics in Pakistan

By Proactive Investors
May 10, 2023

Therma Bright kicks off data collection with AI App at tuberculosis clinics in Pakistan

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it has established collaborations with several tuberculosis (TB) medical care facilities to i more_horizontal

Therma Bright secures US Medicare and Medicaid reimbursement for its Venowave devices

By Proactive Investors
April 14, 2023

Therma Bright secures US Medicare and Medicaid reimbursement for its Venowave devices

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has successfully secured US Medicare and Medicaid reimbursement through various payers, with the rei more_horizontal


Search within

Pages Search Results: